Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion
Elizabeth R. Murray, Shinelle Menezes, Jack C. Henry, et al.
Cell Reports (2022) Vol. 38, Iss. 4, pp. 110227-110227
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer
Ningning Niu, Xuqing Shen, Zheng Wang, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 869-884.e9
Closed Access | Times Cited: 24
Cancer‐associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets
Shinelle Menezes, Mohamed Hazem Okail, Siti Munira Abd Jalil, et al.
The Journal of Pathology (2022) Vol. 257, Iss. 4, pp. 526-544
Open Access | Times Cited: 49
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study
Richard J. Allen, Justin M. Oldham, David Jenkins, et al.
The Lancet Respiratory Medicine (2022) Vol. 11, Iss. 1, pp. 65-73
Open Access | Times Cited: 38
Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma
Cindy Neuzillet, Rémy Nicolle, Jérôme Raffenne, et al.
The Journal of Pathology (2022) Vol. 258, Iss. 4, pp. 408-425
Open Access | Times Cited: 31
A Quick Guide to CAF Subtypes in Pancreatic Cancer
Anna Brichkina, Pierfrancesco Polo, Shrey Dharamvir Sharma, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2614-2614
Open Access | Times Cited: 14
CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy
Keishi Yamashita, Yusuke Kumamoto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6003-6003
Open Access | Times Cited: 5
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 4
Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth
Hangqi Liu, Hui Zhang, Xiaoqian Liu, et al.
Cancer Letters (2022) Vol. 555, pp. 216040-216040
Closed Access | Times Cited: 25
The immunometabolic ecosystem in cancer
Glenn R. Bantug, Christoph Hess
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 2008-2020
Closed Access | Times Cited: 14
Tumor microenvironment as niche constructed by cancer stem cells: Breaking the ecosystem to combat cancer
Hao Zhong, Shiyue Zhou, Shuangshuang Yin, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
Retinoic acid signaling pathway in pancreatic stellate cells: Insight into the anti-fibrotic effect and mechanism
Li Sun, Meifang Zheng, Yanhang Gao, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176374-176374
Open Access | Times Cited: 3
Nerve Growth Factor (NGF) Encourages the Neuroinvasive Potential of Pancreatic Cancer Cells by Activating the Warburg Effect and Promoting Tumor Derived Exosomal miRNA-21 Expression
Tao Peng, Yao Guo, Zheng Gan, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 20
Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1
Abigail S. Coetzee, Edward Carter, Lucia Rodríguez-Fernández, et al.
Oncogene (2022)
Open Access | Times Cited: 15
Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
Weiwei Zhu, Chunquan Liu, Chunting Tan, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23543-e23543
Open Access | Times Cited: 9
Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
Hiroyoshi Tanaka, Takuya Nakazawa, Atsushi Enomoto, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 724-724
Open Access | Times Cited: 8
Chemotherapy Assessment in Advanced Multicellular 3D Models of Pancreatic Cancer: Unravelling the Importance of Spatiotemporal Mimicry of the Tumor Microenvironment
Priyanka Gupta, Camino Bermejo‐Rodríguez, Hemant M. Kocher, et al.
Advanced Biology (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 2
Pancreatic stellate cells: Key players in pancreatic health and diseases (Review)
Zhengfeng Wang, Shi Dong, Wence Zhou
Molecular Medicine Reports (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Targets in the Tumour Matrisome to Promote Cancer Therapy Response
Siti Munira Abd Jalil, Jack C. Henry, Angus J.M. Cameron
Cancers (2024) Vol. 16, Iss. 10, pp. 1847-1847
Open Access | Times Cited: 2
5-FU-miR-15a Inhibits Activation of Pancreatic Stellate Cells by Reducing YAP1 and BCL-2 Levels In Vitro
Vanessa M. Diaz Almanzar, Kunal Shah, Joseph F. LaComb, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3954-3954
Open Access | Times Cited: 7
Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion
Elena Tomas Bort, Megan D. Joseph, Qiaoying Wang, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 7
The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review
Siqi Wu, Zhe Sun, Zehuai Guo, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116565-116565
Closed Access | Times Cited: 7
Neutrophils in pancreatic cancer: Potential therapeutic targets
Wenkai Jiang, Xin Li, Caifei Xiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Advancing Cancer Treatment Through Nanotechnology Driven Immunotherapy for Pancreatic Cancer
Sreejith Thrivikraman Nair, Kaladhar Kamalasanan, Smarakan Sneha, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 20, pp. 18670-18697
Closed Access | Times Cited: 6
Targeting Periostin Expression Makes Pancreatic Cancer Spheroids More Vulnerable to Natural Killer Cells
Didem Karakaş, Merve Erkısa, Remzi Okan Akar, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 270-270
Open Access | Times Cited: 5
CD105+CAF-derived exosomes CircAMPK1 promotes pancreatic cancer progression by activating autophagy
Zhiwei He, Xiushen Li, Shiyu Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top